MatsukiyoCocokara & Co. (TYO:3088)
Japan · Delayed Price · Currency is JPY 3,141.00
-245.00 (-7.24%)
Aug 14, 2025, 3:30 PM JST
United States Steel Revenue
MatsukiyoCocokara & Co. had revenue of 273.64B JPY in the quarter ending June 30, 2025, with 5.35% growth. This brings the company's revenue in the last twelve months to 1.08T, up 4.01% year-over-year. In the fiscal year ending March 31, 2025, MatsukiyoCocokara & Co. had annual revenue of 1.06T with 3.82% growth.
Revenue (ttm)
1,075.52B
Revenue Growth
+4.01%
P/S Ratio
1.16
Revenue / Employee
84.33M
Employees
12,753
Market Cap
1,249.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,061.63B | 39.10B | 3.82% |
| Mar 31, 2024 | 1,022.53B | 71.28B | 7.49% |
| Mar 31, 2023 | 951.25B | 221.28B | 30.31% |
| Mar 31, 2022 | 729.97B | 173.06B | 31.08% |
| Mar 31, 2021 | 556.91B | -33.69B | -5.70% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |